Class / Patent application number | Description | Number of patent applications / Date published |
514628000 | Halogen bonded directly to carbon in R | 11 |
20090062397 | COMPOUNDS AND METHODS FOR ENHANCING SOLUBILITY OF FLORFENICOL AND STRUCTURALLY-RELATED ANTIBIOTICS USING CYCLODEXTRINS - The relatively low solubility of florfenicol (FEC) in water (1.3 mg/mL) limits its use in medicated drinking water systems for treatment of pulmonary disease of swine and poultry. Current formulations use a high volume organic solvent to reach the required FFC concentration of 13.5 mg/mL in an automated proportioner mixing tank system, with practical disadvantages for the users in the field. This invention relates to the effects of complex formation with natural and modified cyclodextrins on the aqueous solubility of FFC and antibiotics of related structure. Furthermore, this invention relates to the effects of polyethylene glycol (PEG-300) as a co-solvent in an FFC-cyclodextrin system to achieve the required FFC dose in the mixing tank system and to avoid high volumes of the organic solvent. | 03-05-2009 |
20090170954 | Process for Recovering Florfenicol and Florfenicol Analogs - This invention is generally directed to a method for recovering florfenicol and florfenicol analogs from pharmaceutical compositions. The recovered florfenicol and analogs can be, for example, reused to make new pharmaceutical compositions and thereby reduce the need and expense of manufacturing new florfenicol and florfenicol analogs. | 07-02-2009 |
20090275662 | Injectable veterinary composition - Injectable veterinary composition comprising a fluorinated chloramphenicol or thiamphenicol derivative and a solvent system comprising an ether of 1,2-ethanediol oligo- or polymers, and a pyrrolidone solvent. | 11-05-2009 |
20090312432 | FLUOROSURFACTANTS - The present invention relates to fatty acid alkanolamides or polyolamides containing at least one group Y, where Y stands for CF | 12-17-2009 |
20100160444 | METHOD TO INHIBIT ISCHEMIA AND REPERFUSION INJURY - Methods of treating or inhibiting ischemia and reperfusion injury are provided. | 06-24-2010 |
20130072565 | METHOD OF INCREASING CELL PROLIFERATION BY ADVANCED WOUND DRESSINGS - The present invention relates generally to a method for stimulating cell proliferation. More specifically this invention discloses the use of increased cell proliferation in treatment of certain wounds. | 03-21-2013 |
20130203857 | Pharmaceutical Compositions for the Treatment of Bacterial Infections - The present invention is related to pharmaceutical compositions capable of inhibiting or eliminating an infectious process caused by bacteria in warm-blooded animals. The present invention describes a stable formulation with a minimized methylpyrrolidone concentration. In order to reduce N-methylpyrrolidone concentration, a mixture was developed that eliminates the need to add preservatives and exhibiting a suitable viscosity and ensures the solubility of the composition when administered in drinking water at a ratio of dilution of up to 5,000 times in chlorinated or non-chlorinated water. | 08-08-2013 |
20130203858 | Fast-Dissolving Solid Pharmaceutical Form for Treating Bacterial Infections - The present invention relates to solid pharmaceutical compositions that dissolve readily and stably and which are capable of inhibiting or eliminating an infectious process caused by bacteria in warm-blooded animals and aquatic species such as, for example, fish and crustaceans. The invention describes composition for formulations containing antibiotics to be administered by various routes for treating bacterial infections in warm-blooded animals and aquatic animals. The formulation can be intended for human and animal use. | 08-08-2013 |
20140323579 | 2,2-DIFLUOROPROPIONAMIDE DERIVATIVES OF BARDOXOLONE METHYL, POLYMORPHIC FORMS AND METHODS OF USE THEREOF - The present invention relates generally to the compound:
| 10-30-2014 |
20150320702 | COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISEASES OR INJURY - Provided are compounds for the treatment of neurological diseases or injuries, including neurodegenerative diseases, stroke, trauma, epilepsy, acute and chronic kidney injuries, diabetes mellitus, and/or seizures. In some embodiments, derivatives of vitamin K are provided. | 11-12-2015 |
20160101182 | DRUG ENTRAPMENT EFFICIENCY AND SUSTAINED DRUG RELEASE OF CHLORAMPHENICOL LOADED POLYMERIC-IRON NANOPARTICLES - This invention harvests nanocomposite which enable targeted delivery of antibiotics. Biodegradable and biocompatible polymer such as diethylaminoethyl-cellulose (DEAE-Cellulose) are used in combination with iron, which contributes its magnetic characteristics to the nanocomposite. The nanoparticles produced could be used as carriers for releasing chloramphenicol at the targeted site for sustained release. | 04-14-2016 |